About: Molecular Partners

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Molecular Partners Goto Sponge NotDistinct Permalink

An Entity of Type : dbo:Organisation, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMolecular_Partners&invfp=IFP_OFF&sas=SAME_AS_OFF

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise organisation
rdfs:label	Molecular Partners (en)
rdfs:comment	Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. (en)
foaf:name	Molecular Partners AG (en)
foaf:homepage	http://www.molecularpartners.com/
name	Molecular Partners AG (en)
foaf:depiction
dcterms:subject	Companies listed on the Nasdaq Pharmaceutical companies established in 2004 Pharmaceutical companies of Switzerland Biotechnology companies established in 2004 2021 initial public offerings Biotechnology companies of Switzerland Biopharmaceutical companies Companies based in Zürich Companies listed on the SIX Swiss Exchange Swiss companies established in 2004
Wikipage page ID	48536390 (xsd:integer)
Wikipage revision ID	1113856398 (xsd:integer)
Link from a Wikipage to another Wikipage	Canton of Zürich Pre-clinical development Public Schlieren, Switzerland Antibody mimetic DARPin University of Zürich Zürich, Switzerland Companies listed on the Nasdaq SIX Swiss Exchange Pharmaceutical companies established in 2004 Ankyrin repeat Chief Financial Officer COVID-19 Pharmaceutical companies of Switzerland Allergan Biotechnology companies established in 2004 Novartis Diagnosis Protein 2021 initial public offerings Biotechnology companies of Switzerland Biopharmaceutical companies Companies based in Zürich Companies listed on the SIX Swiss Exchange Chief Executive Officer Chief Medical Officer Chief Operating Officer Biopharmaceutical Biotechnology Swiss franc Switzerland Swiss companies established in 2004 Oncology Ophthalmology Chairman of the Board Molecular mass Therapeutic Kilodaltons Immuno-oncology Genetically-engineered
Link from a Wikipage to an external page	http://www.molecularpartners.com/
sameAs	Molecular Partners Molecular Partners Molecular Partners
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Reflist dbt:SWX
thumbnail	wiki-commons:Special:FilePath/Molecular_Partners_Logo.jpg?width=300
assets	1.456E8 (swissFranc)
founded	2004 (xsd:integer)
homepage	http://www.molecularpartners.com/
hq location city	Schlieren, Zürich, Switzerland (en)
industry	Biotechnology
key people	Andreas Emmenegger, Chief Financial Officer (en) Dr. Michael Stumpp, Chief Operating Officer (en) Dr. Nicolas Leupin, Chief Medical Officer (en) Dr. Patrick Amstutz, Chief Executive Officer (en) William M. Burns, Chairman of the Board (en)
logo	Molecular_Partners_Logo.jpg (en)
num employees	152 (xsd:integer)
traded as	NASDAQ:MOLN (en)
type	Public
has abstract	Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. (en)
gold:hypernym	Company
prov:wasDerivedFrom	wikipedia-en:Molecular_Partners?oldid=1113856398&ns=0
page length (characters) of wiki page	8739 (xsd:nonNegativeInteger)
assets ($)	1.456E8 (swissFranc)
founding year	2004-01-01 (xsd:gYear)
number of employees	152 (xsd:nonNegativeInteger)
industry	Biotechnology
key person	Chief Financial Officer

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 57 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software